Patty Fritz
Vice President, U.S. Corporate Affairs
Patty Fritz oversees public policy, government affairs, advocacy, communications and public affairs, as well as UCB’s office and strategic priorities in Washington, D.C. Patty leads efforts to create value for patients and their families through strategic engagement and positively influencing the healthcare environment and policy landscape.
In her role, Patty finds opportunities to better understand the unique needs of patients, so we can continue delivering value. She is a champion of innovative projects to spotlight the importance of access and care for people living with severe diseases.
Patty has made a significant impact in different leadership roles including regulatory affairs, operational excellence, government affairs, health policy, and UCBCares®. Patty led the regulatory efforts for UCB’s first product filing in the US - Keppra® (levetiracetam) - and oversaw the FDA approval process for many of UCB’s other products.
Prior to joining UCB, Patty held positions with the government and industry in regulatory affairs, clinical development, and research.
Patty has also championed and was a driving force behind the establishment of UCB’s Women in Leadership initiative. She was recently recognized by PharmaVOICE magazine as one of the 100 most influential and inspirational leaders in the life sciences industry in 2019.
Outside of UCB, Patty serves as chair of the board of directors for Georgia Bio and as a member of The Carter Center Board of Councilors. She splits her time between Washington, D.C. and Atlanta, where she enjoys spending time with her family.
Patty holds a master’s degree in health care policy and administration from Mercer University (Atlanta, Ga.) and a Bachelor of Science degree in management and technology from the University of Maryland (Laurel, Md.). Patty is also a graduate of Summers County School of Nursing (Hinton, W.Va.).